CA2945531C - Signature d'expression d'arnmi dans la classification des tumeurs thyroidiennes - Google Patents
Signature d'expression d'arnmi dans la classification des tumeurs thyroidiennes Download PDFInfo
- Publication number
- CA2945531C CA2945531C CA2945531A CA2945531A CA2945531C CA 2945531 C CA2945531 C CA 2945531C CA 2945531 A CA2945531 A CA 2945531A CA 2945531 A CA2945531 A CA 2945531A CA 2945531 C CA2945531 C CA 2945531C
- Authority
- CA
- Canada
- Prior art keywords
- mir
- hsa
- classifier
- thyroid
- microrna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne une méthode de classification des tumeurs thyroïdiennes basée sur l'analyse des profils d'expression de micro-ARN spécifiques dans des échantillons obtenus par aspiration à l'aiguille fine. La classification des tumeurs thyroïdiennes selon une signature d'expression de micro-ARN permet d'optimiser le diagnostic et le traitement, et de déterminer également une thérapie spécifique de la signature.
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461992756P | 2014-05-13 | 2014-05-13 | |
US201461992531P | 2014-05-13 | 2014-05-13 | |
US61/992,531 | 2014-05-13 | ||
US61/992,756 | 2014-05-13 | ||
US201462069353P | 2014-10-28 | 2014-10-28 | |
US62/069,353 | 2014-10-28 | ||
US201562139066P | 2015-03-27 | 2015-03-27 | |
US62/139,066 | 2015-03-27 | ||
PCT/US2015/030564 WO2015175660A1 (fr) | 2014-05-13 | 2015-05-13 | Signature d'expression d'arnmi dans la classification des tumeurs thyroïdiennes |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2945531A1 CA2945531A1 (fr) | 2015-11-19 |
CA2945531C true CA2945531C (fr) | 2018-01-30 |
Family
ID=54480610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2945531A Expired - Fee Related CA2945531C (fr) | 2014-05-13 | 2015-05-13 | Signature d'expression d'arnmi dans la classification des tumeurs thyroidiennes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP3143162A4 (fr) |
JP (1) | JP6216470B2 (fr) |
CN (1) | CN106460053A (fr) |
BR (1) | BR112016026575A2 (fr) |
CA (1) | CA2945531C (fr) |
IL (1) | IL248639A0 (fr) |
WO (1) | WO2015175660A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106434872A (zh) * | 2016-08-11 | 2017-02-22 | 河南大学 | 一种诊断2型糖尿病的miRNA分子标志物hsa‑miR‑152‑3p及其应用 |
CN107385093A (zh) * | 2017-09-07 | 2017-11-24 | 青岛大学 | 引物组合物及其应用和应用其的产品及产品的使用方法 |
CN107723365B (zh) * | 2017-09-11 | 2019-10-01 | 朱伟 | 一种与肺鳞癌辅助诊断相关的血浆miRNA标志物及其应用 |
CN108038352B (zh) * | 2017-12-15 | 2021-09-14 | 西安电子科技大学 | 结合差异化分析和关联规则挖掘全基因组关键基因的方法 |
CA3088939A1 (fr) * | 2018-01-05 | 2019-07-11 | Visiongate, Inc. | Genotypage morphometrique de cellules par tomographie optique pour detecter une charge de mutation de tumeur |
BR102018003587A2 (pt) * | 2018-02-23 | 2020-07-07 | Onkos Diagnósticos Moleculares Ltda Me | método e kit para detecção de tipo de tumor de tireoide |
CN108721318B (zh) * | 2018-05-16 | 2021-06-25 | 广东药科大学 | miR-125b和化疗剂在制备治疗甲状腺癌的药物中的应用 |
JP7378739B2 (ja) * | 2018-08-10 | 2023-11-14 | 東レ株式会社 | 前立腺がんの検出のためのキット、デバイス及び方法 |
CN109700824A (zh) * | 2019-01-08 | 2019-05-03 | 上海长海医院 | miR-31及其类似物在制备预防或治疗血管内皮损伤的药物中的应用 |
CN110499367B (zh) * | 2019-08-09 | 2022-11-22 | 深圳市第二人民医院 | 生物标志物及其应用 |
CN113025714B (zh) * | 2021-03-23 | 2022-05-24 | 华中科技大学同济医学院附属同济医院 | 用于甲状腺乳头状癌颈侧方淋巴结转移诊断的miRNA生物标志物及检测试剂盒 |
CN116769922B (zh) * | 2023-08-24 | 2023-11-24 | 四川大学华西医院 | 检测循环sEV RNA试剂的用途、试剂盒和诊断系统 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011154008A1 (fr) * | 2010-06-11 | 2011-12-15 | Rigshospitalet | Classification de micro-arn de néoplasie folliculaire de la thyroïde |
JP2014511677A (ja) * | 2011-03-22 | 2014-05-19 | コーネル・ユニバーシティー | 鑑別困難な良性甲状腺病変と悪性甲状腺病変との識別法 |
US20130142728A1 (en) * | 2011-10-27 | 2013-06-06 | Asuragen, Inc. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
-
2015
- 2015-05-13 EP EP15792258.4A patent/EP3143162A4/fr active Pending
- 2015-05-13 JP JP2016567582A patent/JP6216470B2/ja not_active Expired - Fee Related
- 2015-05-13 CA CA2945531A patent/CA2945531C/fr not_active Expired - Fee Related
- 2015-05-13 BR BR112016026575A patent/BR112016026575A2/pt not_active Application Discontinuation
- 2015-05-13 CN CN201580024961.9A patent/CN106460053A/zh active Pending
- 2015-05-13 WO PCT/US2015/030564 patent/WO2015175660A1/fr active Application Filing
-
2016
- 2016-10-31 IL IL248639A patent/IL248639A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3143162A1 (fr) | 2017-03-22 |
IL248639A0 (en) | 2017-01-31 |
WO2015175660A1 (fr) | 2015-11-19 |
BR112016026575A2 (pt) | 2017-12-12 |
CN106460053A (zh) | 2017-02-22 |
JP2017521051A (ja) | 2017-08-03 |
EP3143162A4 (fr) | 2017-04-26 |
JP6216470B2 (ja) | 2017-10-18 |
CA2945531A1 (fr) | 2015-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9708667B2 (en) | MiRNA expression signature in the classification of thyroid tumors | |
CA2945531C (fr) | Signature d'expression d'arnmi dans la classification des tumeurs thyroidiennes | |
KR101900872B1 (ko) | 조기 대장암 검출을 위한 혈장 마이크로rna | |
Wu et al. | Next‐generation sequencing of microRNAs for breast cancer detection | |
US20180105888A1 (en) | Methods and Kits for Detecting Subjects at Risk of Having Cancer | |
Li et al. | Identification of aberrantly expressed miRNAs in rectal cancer | |
US10457994B2 (en) | 4-miRNA signature for predicting clear cell renal cell carcinoma metastasis and prognosis | |
US20110160290A1 (en) | Use of extracellular rna to measure disease | |
AU2018202963B2 (en) | Biomarkers useful for detection of types, grades and stages of human breast cancer | |
MX2013013746A (es) | Biomarcadores para cancer de pulmon. | |
WO2009133915A1 (fr) | Marqueur de cancer, procédé d’évaluation du cancer utilisant le marqueur de cancer et réactif d’évaluation | |
CA2836836A1 (fr) | Procedes et dispositifs pour le pronostic d'une rechute du cancer | |
US9068232B2 (en) | Gene expression signature for classification of kidney tumors | |
WO2011154008A1 (fr) | Classification de micro-arn de néoplasie folliculaire de la thyroïde | |
WO2017079571A1 (fr) | Procédé pour l'identification de patients à risque de carcinome à cellules squameuses orales | |
JP2022536502A (ja) | 癌を治療するための組成物および方法 | |
US20140243230A1 (en) | Gene expression signature for classification of kidney tumors | |
Attia et al. | Altered expression of microRNAs in the bone marrow of multiple myeloma patients and their relationship to cytogenetic aberrations | |
KR20130098669A (ko) | 위암의 림프절 전이 진단 마커로서의 혈청 miRNA | |
Rghebi | Circulating nucleic acids as biomarkers of breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20161220 |
|
MKLA | Lapsed |
Effective date: 20220301 |
|
MKLA | Lapsed |
Effective date: 20200831 |